Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-N-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S)-23-((1H-indol-3-yl)methyl)-1,51-diamino-8,17,29,41-tetrakis(4-aminobutyl)-11,35-dibenzyl-2,5,14,20,26,32,38,44-octamethyl-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46-hexadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaazahenpentacontan-47-yl)-2,6-diaminohexanamide
ID: ALA4561075
PubChem CID: 155558600
Max Phase: Preclinical
Molecular Formula: C89H143N25O17
Molecular Weight: 1835.28
Molecule Type: Unknown
Associated Items: